Logo image of CHR.CA

CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CHR - CA17040T8885 - Common Stock

21.14 CAD
+0.14 (+0.67%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

5

CHR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 5 industry peers in the Passenger Airlines industry. CHR has only an average score on both its financial health and profitability. CHR is valued quite cheap, but it does not seem to be growing. This makes CHR very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CHR had positive earnings in the past year.
In the past year CHR had a positive cash flow from operations.
In multiple years CHR reported negative net income over the last 5 years.
CHR had a positive operating cash flow in each of the past 5 years.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

The Return On Assets of CHR (-2.62%) is comparable to the rest of the industry.
CHR has a better Return On Equity (-6.31%) than 83.33% of its industry peers.
With an excellent Return On Invested Capital value of 6.40%, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 3.84%.
The last Return On Invested Capital (6.40%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROIC 6.4%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

CHR has a better Operating Margin (6.81%) than 83.33% of its industry peers.
In the last couple of years the Operating Margin of CHR has declined.
Looking at the Gross Margin, with a value of 65.68%, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.81%
PM (TTM) N/A
GM 65.68%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CHR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHR has more shares outstanding
CHR has a better debt/assets ratio than last year.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that CHR is in the distress zone and has some risk of bankruptcy.
CHR has a Altman-Z score (0.90) which is in line with its industry peers.
CHR has a debt to FCF ratio of 10.63. This is a negative value and a sign of low solvency as CHR would need 10.63 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.63, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CHR has a Debt/Equity ratio of 0.50. This is a neutral value indicating CHR is somewhat dependend on debt financing.
CHR has a better Debt to Equity ratio (0.50) than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Altman-Z 0.9
ROIC/WACC0.79
WACC8.07%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CHR has a Current Ratio of 1.22. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, CHR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CHR has a Quick Ratio of 1.22. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.63, CHR is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.63
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

CHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.86%, which is quite impressive.
CHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
CHR shows a decrease in Revenue. In the last year, the revenue decreased by -8.40%.
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%

3.2 Future

Based on estimates for the next years, CHR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.19% on average per year.
CHR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.52% yearly.
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

CHR is valuated reasonably with a Price/Earnings ratio of 8.70.
Compared to the rest of the industry, the Price/Earnings ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.92, CHR is valued rather cheaply.
With a Price/Forward Earnings ratio of 10.75, the valuation of CHR can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CHR is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CHR to the average of the S&P500 Index (23.46), we can say CHR is valued rather cheaply.
Industry RankSector Rank
PE 8.7
Fwd PE 10.75
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CHR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHR is cheaper than 83.33% of the companies in the same industry.
CHR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHR is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.24
EV/EBITDA 3.86
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

CHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHR has a very decent profitability rating, which may justify a higher PE ratio.
CHR's earnings are expected to grow with 14.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y14.11%
EPS Next 3Y14.19%

3

5. Dividend

5.1 Amount

CHR has a Yearly Dividend Yield of 1.51%.
Compared to an average industry Dividend Yield of 0.96, CHR pays a bit more dividend than its industry peers.
CHR's Dividend Yield is slightly below the S&P500 average, which is at 2.00.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

The dividend of CHR is nicely growing with an annual growth rate of 21.58%!
CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 1 2 3

5.3 Sustainability

CHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-5.89%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR (12/24/2025, 7:00:00 PM)

21.14

+0.14 (+0.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners3.79%
Inst Owner ChangeN/A
Ins Owners1.48%
Ins Owner ChangeN/A
Market Cap495.10M
Revenue(TTM)1.35B
Net Income(TTM)-34.96M
Analysts78
Price Target30.26 (43.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-12 2025-12-12 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)5.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)4.04%
EPS NY rev (3m)4.22%
Revenue NQ rev (1m)-2.01%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)-1.68%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE 8.7
Fwd PE 10.75
P/S 0.37
P/FCF 15.24
P/OCF 6.95
P/B 0.89
P/tB 0.91
EV/EBITDA 3.86
EPS(TTM)2.43
EY11.49%
EPS(NY)1.97
Fwd EY9.3%
FCF(TTM)1.39
FCFY6.56%
OCF(TTM)3.04
OCFY14.38%
SpS57.62
BVpS23.67
TBVpS23.29
PEG (NY)0.14
PEG (5Y)N/A
Graham Number35.98
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROCE 8.63%
ROIC 6.4%
ROICexc 6.56%
ROICexgc 6.62%
OM 6.81%
PM (TTM) N/A
GM 65.68%
FCFM 2.41%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Debt/EBITDA 1.32
Cap/Depr 32.58%
Cap/Sales 2.87%
Interest Coverage 2.74
Cash Conversion 33.79%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.63
Altman-Z 0.9
F-Score6
WACC8.07%
ROIC/WACC0.79
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year87.77%
EBIT Next 3Y14.37%
EBIT Next 5YN/A
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 5 / 10 to CHR.CA.


What is the valuation status for CHR stock?

ChartMill assigns a valuation rating of 8 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Undervalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CHORUS AVIATION INC (CHR.CA) stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 8.7 and the Price/Book (PB) ratio is 0.89.


What is the expected EPS growth for CHORUS AVIATION INC (CHR.CA) stock?

The Earnings per Share (EPS) of CHORUS AVIATION INC (CHR.CA) is expected to grow by 61.87% in the next year.